Table 3a.

Multiple Linear Regression assessing Best Spectacle-Corrected Visual Acuity.Results from three separate multiple linear regression models predicting 3-month Best Spectacle-Corrected Visual Acuity (logMAR) for patients testing positive (vs. negative) for presence of fungus at day-6, while correcting for treatment arm and baseline Best Spectacle-Corrected Visual Acuity.

Predictor	N	3-month BSCVAa (logMAR)	95% CI	P
Enrollment Culture Positivity	292	0.12	(−0.03 to 0.27)	0.11
Day-6 Culture Positivity	274	0.42	(.28 to 0.56)	<0.001
Day-6 Smear Positivity	275	0.35	(0.22 to 0.48)	<0.001

^aBest Spectacle-Corrected Visual Acuity;